[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Myotubular Myopathy Treatment Supply, Demand and Key Producers, 2023-2029

May 2023 | 97 pages | ID: G13FB19DB3E5EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Myotubular Myopathy Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Myotubular Myopathy Treatment demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Myotubular Myopathy Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Myotubular Myopathy Treatment that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Myotubular Myopathy Treatment total market, 2018-2029, (USD Million)

Global Myotubular Myopathy Treatment total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Myotubular Myopathy Treatment total market, key domestic companies and share, (USD Million)

Global Myotubular Myopathy Treatment revenue by player and market share 2018-2023, (USD Million)

Global Myotubular Myopathy Treatment total market by Type, CAGR, 2018-2029, (USD Million)

Global Myotubular Myopathy Treatment total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Myotubular Myopathy Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ARMGO Pharma, Astellas Pharma US, Audentes Therapeutics, Dynacure, Genethon and Valerion Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Myotubular Myopathy Treatment market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Myotubular Myopathy Treatment Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Myotubular Myopathy Treatment Market, Segmentation by Type
  • Diagnosis
  • Treatment
  • Other
Global Myotubular Myopathy Treatment Market, Segmentation by Application
  • Mild to Moderate Myotubular Myopathy
  • Severe Myotubular Myopathy
Companies Profiled:
  • ARMGO Pharma
  • Astellas Pharma US
  • Audentes Therapeutics
  • Dynacure
  • Genethon
  • Valerion Therapeutics
Key Questions Answered

1. How big is the global Myotubular Myopathy Treatment market?

2. What is the demand of the global Myotubular Myopathy Treatment market?

3. What is the year over year growth of the global Myotubular Myopathy Treatment market?

4. What is the total value of the global Myotubular Myopathy Treatment market?

5. Who are the major players in the global Myotubular Myopathy Treatment market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Myotubular Myopathy Treatment Introduction
1.2 World Myotubular Myopathy Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Myotubular Myopathy Treatment Total Market by Region (by Headquarter Location)
  1.3.1 World Myotubular Myopathy Treatment Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Myotubular Myopathy Treatment Market Size (2018-2029)
  1.3.3 China Myotubular Myopathy Treatment Market Size (2018-2029)
  1.3.4 Europe Myotubular Myopathy Treatment Market Size (2018-2029)
  1.3.5 Japan Myotubular Myopathy Treatment Market Size (2018-2029)
  1.3.6 South Korea Myotubular Myopathy Treatment Market Size (2018-2029)
  1.3.7 ASEAN Myotubular Myopathy Treatment Market Size (2018-2029)
  1.3.8 India Myotubular Myopathy Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Myotubular Myopathy Treatment Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Myotubular Myopathy Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Myotubular Myopathy Treatment Consumption Value (2018-2029)
2.2 World Myotubular Myopathy Treatment Consumption Value by Region
  2.2.1 World Myotubular Myopathy Treatment Consumption Value by Region (2018-2023)
  2.2.2 World Myotubular Myopathy Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Myotubular Myopathy Treatment Consumption Value (2018-2029)
2.4 China Myotubular Myopathy Treatment Consumption Value (2018-2029)
2.5 Europe Myotubular Myopathy Treatment Consumption Value (2018-2029)
2.6 Japan Myotubular Myopathy Treatment Consumption Value (2018-2029)
2.7 South Korea Myotubular Myopathy Treatment Consumption Value (2018-2029)
2.8 ASEAN Myotubular Myopathy Treatment Consumption Value (2018-2029)
2.9 India Myotubular Myopathy Treatment Consumption Value (2018-2029)

3 WORLD MYOTUBULAR MYOPATHY TREATMENT COMPANIES COMPETITIVE ANALYSIS

3.1 World Myotubular Myopathy Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Myotubular Myopathy Treatment Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Myotubular Myopathy Treatment in 2022
  3.2.3 Global Concentration Ratios (CR8) for Myotubular Myopathy Treatment in 2022
3.3 Myotubular Myopathy Treatment Company Evaluation Quadrant
3.4 Myotubular Myopathy Treatment Market: Overall Company Footprint Analysis
  3.4.1 Myotubular Myopathy Treatment Market: Region Footprint
  3.4.2 Myotubular Myopathy Treatment Market: Company Product Type Footprint
  3.4.3 Myotubular Myopathy Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Myotubular Myopathy Treatment Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Myotubular Myopathy Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Myotubular Myopathy Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Myotubular Myopathy Treatment Consumption Value Comparison
  4.2.1 United States VS China: Myotubular Myopathy Treatment Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Myotubular Myopathy Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Myotubular Myopathy Treatment Companies and Market Share, 2018-2023
  4.3.1 United States Based Myotubular Myopathy Treatment Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Myotubular Myopathy Treatment Revenue, (2018-2023)
4.4 China Based Companies Myotubular Myopathy Treatment Revenue and Market Share, 2018-2023
  4.4.1 China Based Myotubular Myopathy Treatment Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Myotubular Myopathy Treatment Revenue, (2018-2023)
4.5 Rest of World Based Myotubular Myopathy Treatment Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Myotubular Myopathy Treatment Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Myotubular Myopathy Treatment Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Myotubular Myopathy Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Diagnosis
  5.2.2 Treatment
  5.2.3 Other
5.3 Market Segment by Type
  5.3.1 World Myotubular Myopathy Treatment Market Size by Type (2018-2023)
  5.3.2 World Myotubular Myopathy Treatment Market Size by Type (2024-2029)
  5.3.3 World Myotubular Myopathy Treatment Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Myotubular Myopathy Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Mild to Moderate Myotubular Myopathy
  6.2.2 Severe Myotubular Myopathy
6.3 Market Segment by Application
  6.3.1 World Myotubular Myopathy Treatment Market Size by Application (2018-2023)
  6.3.2 World Myotubular Myopathy Treatment Market Size by Application (2024-2029)
  6.3.3 World Myotubular Myopathy Treatment Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 ARMGO Pharma
  7.1.1 ARMGO Pharma Details
  7.1.2 ARMGO Pharma Major Business
  7.1.3 ARMGO Pharma Myotubular Myopathy Treatment Product and Services
  7.1.4 ARMGO Pharma Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 ARMGO Pharma Recent Developments/Updates
  7.1.6 ARMGO Pharma Competitive Strengths & Weaknesses
7.2 Astellas Pharma US
  7.2.1 Astellas Pharma US Details
  7.2.2 Astellas Pharma US Major Business
  7.2.3 Astellas Pharma US Myotubular Myopathy Treatment Product and Services
  7.2.4 Astellas Pharma US Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Astellas Pharma US Recent Developments/Updates
  7.2.6 Astellas Pharma US Competitive Strengths & Weaknesses
7.3 Audentes Therapeutics
  7.3.1 Audentes Therapeutics Details
  7.3.2 Audentes Therapeutics Major Business
  7.3.3 Audentes Therapeutics Myotubular Myopathy Treatment Product and Services
  7.3.4 Audentes Therapeutics Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Audentes Therapeutics Recent Developments/Updates
  7.3.6 Audentes Therapeutics Competitive Strengths & Weaknesses
7.4 Dynacure
  7.4.1 Dynacure Details
  7.4.2 Dynacure Major Business
  7.4.3 Dynacure Myotubular Myopathy Treatment Product and Services
  7.4.4 Dynacure Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Dynacure Recent Developments/Updates
  7.4.6 Dynacure Competitive Strengths & Weaknesses
7.5 Genethon
  7.5.1 Genethon Details
  7.5.2 Genethon Major Business
  7.5.3 Genethon Myotubular Myopathy Treatment Product and Services
  7.5.4 Genethon Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Genethon Recent Developments/Updates
  7.5.6 Genethon Competitive Strengths & Weaknesses
7.6 Valerion Therapeutics
  7.6.1 Valerion Therapeutics Details
  7.6.2 Valerion Therapeutics Major Business
  7.6.3 Valerion Therapeutics Myotubular Myopathy Treatment Product and Services
  7.6.4 Valerion Therapeutics Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Valerion Therapeutics Recent Developments/Updates
  7.6.6 Valerion Therapeutics Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Myotubular Myopathy Treatment Industry Chain
8.2 Myotubular Myopathy Treatment Upstream Analysis
8.3 Myotubular Myopathy Treatment Midstream Analysis
8.4 Myotubular Myopathy Treatment Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Myotubular Myopathy Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Myotubular Myopathy Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Myotubular Myopathy Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Myotubular Myopathy Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Myotubular Myopathy Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Myotubular Myopathy Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Myotubular Myopathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Myotubular Myopathy Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Myotubular Myopathy Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Myotubular Myopathy Treatment Players in 2022
Table 12. World Myotubular Myopathy Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Myotubular Myopathy Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Myotubular Myopathy Treatment Player
Table 15. Myotubular Myopathy Treatment Market: Company Product Type Footprint
Table 16. Myotubular Myopathy Treatment Market: Company Product Application Footprint
Table 17. Myotubular Myopathy Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Myotubular Myopathy Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Myotubular Myopathy Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Myotubular Myopathy Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Myotubular Myopathy Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Myotubular Myopathy Treatment Revenue Market Share (2018-2023)
Table 23. China Based Myotubular Myopathy Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Myotubular Myopathy Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Myotubular Myopathy Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Myotubular Myopathy Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Myotubular Myopathy Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Myotubular Myopathy Treatment Revenue Market Share (2018-2023)
Table 29. World Myotubular Myopathy Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Myotubular Myopathy Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Myotubular Myopathy Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Myotubular Myopathy Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Myotubular Myopathy Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Myotubular Myopathy Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. ARMGO Pharma Basic Information, Area Served and Competitors
Table 36. ARMGO Pharma Major Business
Table 37. ARMGO Pharma Myotubular Myopathy Treatment Product and Services
Table 38. ARMGO Pharma Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. ARMGO Pharma Recent Developments/Updates
Table 40. ARMGO Pharma Competitive Strengths & Weaknesses
Table 41. Astellas Pharma US Basic Information, Area Served and Competitors
Table 42. Astellas Pharma US Major Business
Table 43. Astellas Pharma US Myotubular Myopathy Treatment Product and Services
Table 44. Astellas Pharma US Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Astellas Pharma US Recent Developments/Updates
Table 46. Astellas Pharma US Competitive Strengths & Weaknesses
Table 47. Audentes Therapeutics Basic Information, Area Served and Competitors
Table 48. Audentes Therapeutics Major Business
Table 49. Audentes Therapeutics Myotubular Myopathy Treatment Product and Services
Table 50. Audentes Therapeutics Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Audentes Therapeutics Recent Developments/Updates
Table 52. Audentes Therapeutics Competitive Strengths & Weaknesses
Table 53. Dynacure Basic Information, Area Served and Competitors
Table 54. Dynacure Major Business
Table 55. Dynacure Myotubular Myopathy Treatment Product and Services
Table 56. Dynacure Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Dynacure Recent Developments/Updates
Table 58. Dynacure Competitive Strengths & Weaknesses
Table 59. Genethon Basic Information, Area Served and Competitors
Table 60. Genethon Major Business
Table 61. Genethon Myotubular Myopathy Treatment Product and Services
Table 62. Genethon Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Genethon Recent Developments/Updates
Table 64. Valerion Therapeutics Basic Information, Area Served and Competitors
Table 65. Valerion Therapeutics Major Business
Table 66. Valerion Therapeutics Myotubular Myopathy Treatment Product and Services
Table 67. Valerion Therapeutics Myotubular Myopathy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 68. Global Key Players of Myotubular Myopathy Treatment Upstream (Raw Materials)
Table 69. Myotubular Myopathy Treatment Typical Customers

LIST OF FIGURES

Figure 1. Myotubular Myopathy Treatment Picture
Figure 2. World Myotubular Myopathy Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Myotubular Myopathy Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Myotubular Myopathy Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Myotubular Myopathy Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Myotubular Myopathy Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Myotubular Myopathy Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Myotubular Myopathy Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Myotubular Myopathy Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Myotubular Myopathy Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Myotubular Myopathy Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Myotubular Myopathy Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Myotubular Myopathy Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Myotubular Myopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Myotubular Myopathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Myotubular Myopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Myotubular Myopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Myotubular Myopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Myotubular Myopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Myotubular Myopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Myotubular Myopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Myotubular Myopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Myotubular Myopathy Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Myotubular Myopathy Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Myotubular Myopathy Treatment Markets in 2022
Figure 27. United States VS China: Myotubular Myopathy Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Myotubular Myopathy Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Myotubular Myopathy Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Myotubular Myopathy Treatment Market Size Market Share by Type in 2022
Figure 31. Diagnosis
Figure 32. Treatment
Figure 33. Other
Figure 34. World Myotubular Myopathy Treatment Market Size Market Share by Type (2018-2029)
Figure 35. World Myotubular Myopathy Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Myotubular Myopathy Treatment Market Size Market Share by Application in 2022
Figure 37. Mild to Moderate Myotubular Myopathy
Figure 38. Severe Myotubular Myopathy
Figure 39. Myotubular Myopathy Treatment Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source


More Publications